Group 1: Financial Performance - In 2025, the company achieved total revenue of 2.146 billion RMB, a year-on-year increase of 40.39% [14] - The net profit attributable to shareholders reached 228 million RMB, growing by 118.74% compared to the previous year [14] - As of December 31, 2025, cash and cash equivalents amounted to 9.251 billion RMB, accounting for 60% of total assets [5] Group 2: Stock Price and Market Strategy - The company's stock price has declined over 30% from its peak, prompting concerns among investors [3] - The company plans to enhance operational efficiency and optimize shareholder return schemes to stabilize stock prices [5] - The company has not disclosed any plans for share buybacks or increases in dividends despite high valuation levels [11] Group 3: Business Development and Integration - The company completed the acquisition of a 22.5050% stake in Beijing Pengkang Investment Co., Ltd. and a 33.3074% stake in Dalian Yalian Investment Management Co., Ltd. in 2025 [4] - The integration of Maigao Securities and Pioneer Fund is aimed at enhancing capital strength and supporting future business development [6] - The company is focusing on product innovation and functional optimization to strengthen its core business [7] Group 4: Marketing and Sales Expenses - Sales expenses reached 1.11 billion RMB in 2025, a year-on-year increase of 38%, with advertising and online promotion costs rising by 67% [10] - The company aims to balance marketing investments with profit growth to ensure sustainable development [16] Group 5: Future Outlook and Challenges - The company anticipates that 3.96 billion RMB of its 9.21 billion RMB in advance receipts will be recognized as revenue in 2026 [10] - The management is focused on maintaining financial stability and liquidity while considering refinancing options as needed [12] - The company acknowledges the challenges in achieving consistent financial performance due to the nature of its business model and sales cycles [14]

Core Viewpoint - The company has officially launched a new strategic plan called "One Body, Two Wings" as of July 2025, focusing on enhancing its core advantages in the geographic information industry while expanding into commercial aerospace and low-altitude economy sectors [2] Group 1: Strategic Focus - "One Body" refers to the company's commitment to solidifying and deepening its core advantages in the geographic information industry, with an emphasis on building a digital earth core capability platform [2] - The company aims to actively integrate artificial intelligence technology to evolve its platform from a data processing tool to an intelligent decision-making platform [2] Group 2: New Market Areas - "Two Wings" focuses on the emerging fields of commercial aerospace and low-altitude economy, with the goal of establishing comprehensive service capabilities across the entire value chain [2]

Core Viewpoint - Longjiang Transportation (601188) has recently experienced a rise in stock price, with net inflow of funds, while facing low institutional attention and a neutral rating due to risks related to the expiration of its main business operating rights [1][4]. Stock Performance - On February 10, 2026, Longjiang Transportation's stock closed at 3.67 CNY, up 0.82% with a trading volume of 70.91 million CNY; net inflow from main funds was 2.22 million CNY, accounting for 3.14% of total trading volume, indicating increased short-term market confidence [2]. - On February 11, 2026, the stock adjusted slightly to 3.66 CNY (down 0.27%), with a five-day volatility of 1.91%, showing overall performance in line with the market [2]. - Retail investors saw a net inflow of 1.57 million CNY on February 10, while speculative funds experienced a net outflow of 3.80 million CNY, indicating existing market divergence [2]. Recent Events - The company announced a change in its auditing firm (Zhongshen Yatai Accounting Firm) on February 11-12, 2026, involving a change in project partners and quality reviewers, which is an internal adjustment expected to have no adverse impact on the 2025 annual audit [3]. - A temporary board meeting was held on February 9, 2026, to review the board's re-election proposal, potentially paving the way for future strategic adjustments, though specific details remain undisclosed [3]. Institutional Perspectives - Institutional attention towards Longjiang Transportation is low, with the latest rating being neutral; profit forecasts indicate an expected 8.03% year-on-year increase in net profit for 2025, although revenue may see a slight decline [4]. - In the long term, the company is expected to benefit from transportation infrastructure policies and its "one body, two wings" strategy, but attention is needed on the expiration of its main business operating rights in 2029 and risks associated with new business investments [4].

Core Viewpoint - Northeast Pharmaceutical is implementing a "one body, two wings" development strategy to enhance resilience and profitability amid industry challenges and market competition [1] Group 1: Operational Efficiency and Market Strategy - The company is focusing on improving operational quality and market expansion, with a steady increase in core business foundations [2] - By 2025, the company aims for multiple breakthroughs in market layout, with core products achieving historical sales highs and brand influence steadily increasing [2] - The raw materials segment is adapting to market fluctuations by optimizing sales structures and expanding into emerging fields, solidifying its market position [2] Group 2: Production and Quality Control - Northeast Pharmaceutical has achieved cost reduction and efficiency improvements while maintaining a 100% product pass rate for factory output and inspections [3] - The company is enhancing production efficiency through process optimization, equipment upgrades, and management improvements [3] Group 3: Research and Innovation - The company is driving growth through both generic and innovative drugs, with three new generic products approved for market by March 2025 [3] - Ongoing projects in biopharmaceuticals and health products are being developed, including new health-oriented products like functional skincare items [3] Group 4: Strategic Development Framework - The "one body, two wings" strategy aims to strengthen the core business of chemical generics while expanding into biopharmaceuticals and traditional Chinese medicine [4] - The company plans to enhance its competitive advantage and market influence across all business segments, focusing on key product sales and overseas promotion of certified products [4] Group 5: Support Systems for Strategy Implementation - To ensure the effective implementation of the "one body, two wings" strategy, the company is optimizing management mechanisms and enhancing operational efficiency [5] - The focus is on risk management, cost control, and digital transformation to improve overall business quality [5] Group 6: Future Growth Drivers - The core growth drivers for the company include the successful transformation of innovative research results and the internationalization of the raw materials business [6] - Digital management and efficiency improvements are also seen as positive factors for driving performance growth [6]

● 本报记者 宋维东 东北制药相关负责人日前在接受中国证券报记者采访时表示，面对行业调整、市场竞争加剧等多重挑 战，公司将锚定"一体两翼"发展战略，坚持稳健经营与创新突破并举，深耕医药核心主业，拓展多元赛 道，打造更多盈利增长点，持续增强发展韧性。 运营质效持续提升 "在药品集采常态化、医保改革持续深化、行业竞争日趋激烈的背景下，东北制药紧扣'变、干、实'工 作总要求，主动适应行业变革，在经营提质、市场拓展、生产增效、研发创新等方面协同发力，发展质 效稳步提升，核心业务根基持续夯实。"该负责人说。 2025年，公司市场布局多点突破，营销效能持续释放。其中，制剂板块聚焦核心产品，深耕终端市场， 渠道覆盖与市场渗透力不断增强，多款主导产品销量创历史新高，新开发终端与主要品种覆盖率均同比 增长，品牌影响力稳步提升。此外，原料药板块积极应对国内外市场波动，通过优化产品销售结构、拓 展新兴领域等举措，核心产品市场地位不断稳固，海外市场持续拓展。该负责人表示，公司各子公司协 同发力，部分子公司成功扭亏为盈，构筑起多元协同、稳健向好的发展格局。 在生产运营方面，东北制药实现降本增效与质量管控双线提升。公司构建了"产销协同、 ...

Core Viewpoint - The company believes that the adjustment of downstream orders is a short-term fluctuation in the industry and is actively implementing its "one body, two wings" strategy to enhance product structure and market reach [1] Group 1: Company Strategy - The company is focusing on high-end equipment using titanium alloy materials and forgings as the "one body" of its strategy [1] - The "two wings" of the strategy involve the development of materials for civil aviation and marine equipment components, aiming to diversify product applications [1] Group 2: Market Outlook - The company anticipates that the combination of domestic and international markets for dual-use items will lead to a gradual improvement in orders over the long term [1]

证券日报网1月30日讯，天原股份（002386）在接受调研者提问时表示，公司"十五五"规划仍然是围 绕"一体两翼"战略目标，持续在氯化法钛白粉和新能源电池材料方面深耕，目前公司新产业（300832） 已经形成并进入发展期，"十五五"期间将在现有产业链进行延链、补链、强链。 ...

投资者关系活动记录表 | 编号：2026-001 | | --- | | 投资者关系活动类别 | 特定对象调研 ☐ 分析师会议 | | --- | --- | | | ☐ 媒体采访 ☐ 业绩说明会 | | | ☐ 新闻发布会 ☐ 路演活动 | | | ☐ 现场参观 | | | 其他（请文字说明其他活动内容） ☐ 农银汇理基金汤砚卿、鹏扬基金梁君岳、华泰资产王曦炜、长城基 | | | 金李金鸿、天风证券唐婕、东方证券倪吉、东方证券万里扬、东方 | | 参与单位名称及人员姓名 | | | | 财富证券汪智谦 | | 时间 | 2026年01月28日 15:00-17:00 | | 地点 | 宜宾天原集团股份有限公司会议室 | | | 董事会秘书 何波 | | | 副总会计师 陶铸 | | 上市公司接待人员姓名 | 海丰和泰副总经理 梁波 | | | 证券事务代表 张梦、谢明洋 | | | 锂电新材销售经理 邓雨亮 | | | 1. 公司"十五五"战略规划？ | | | 答:公司"十五五"规划仍然是围绕"一体两翼"战略目标，持 | | 投资者关系活动主要内容 | 续在氯化法钛白粉和新能源电池材料方面深耕，目前公司 ...

证券日报网讯1月29日，诚志股份（000990）在互动平台回答投资者提问时表示，公司坚持"一体两 翼"总体业务战略，在新的发展阶段，公司立足长远，全面启动"诚志股份2.0版"战略规划，在现有"一 体两翼"产业格局基础上进行深化与升级，加速向化工新材料、高端半导体显示材料、合成生物学等高 精尖领域延伸产业链，通过产业创新、科技创新、管理创新不断提升核心竞争力，为公司高质量发展注 入强劲动力。 ...

Group 1: Company Transformation and Strategy - The company is transitioning from equipment manufacturing to mining operation services, driven by solid talent reserves, extensive engineering experience, and significant equipment and technology advantages [2] - The strategic focus includes recruiting specialized personnel and adopting a "co-investment rather than control" model for overseas mining operations to manage investment risks [2] Group 2: Growth Drivers in Aftermarket Business - The growth of the aftermarket business is driven by product compatibility, alignment with customer needs, and innovative business models combining equipment sales with total production contracting [3] Group 3: Overseas Business Expansion - High growth in overseas business is attributed to a low initial base and a shift from trade to a long-term model involving local warehousing and service provision, supported by strong market demand [4] Group 4: Risk Management in Mining Operations - Core risks include external uncertainties in target mining environments, with mitigation strategies focusing on project selection, investment model optimization, and enhancing operational efficiency through smart management [5] Group 5: Competitive Advantages in Smart Operations - The company's competitive edge in smart operations lies in reliable equipment manufacturing, a comprehensive service system, and a closed-loop business model that fosters continuous product and technology improvement [6] Group 6: Strategic Framework and Investment Priorities - The "one core, two wings" strategy emphasizes equipment manufacturing while balancing resource investment and service operations, prioritizing gold and copper mining projects to manage investment risks effectively [7] Group 7: Financial Performance and Profitability - The company anticipates limited operational leverage increase due to industry characteristics, with profit margin expansion potential linked to the growth of aftermarket and overseas business contributions [8]